Rivaroxaban
- PDF / 168,728 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 5 Downloads / 158 Views
1 S
Bleeding: case report In a prospective study involving 108 cancer patients, one patient [age and sex not stated] was described, who developed bleeding secondary to rivaroxaban [route and dosage not stated] while receiving treatment for venous thromboembolism [outcome not stated]. Ng HK, et al. Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation. Journal of Oncology Pharmacy Practice 803520714 26: 1637-1642, No. 7, Oct 2020. Available from: URL: http://doi.org/10.1177/1078155220901569
0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Dec 2020 No. 1834
Data Loading...
